138 related articles for article (PubMed ID: 31594835)
21. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
22. Pure dysgerminoma of the ovary: a single institutional experience of 65 patients.
A L Husaini H; Soudy H; El Din Darwish A; Ahmed M; Eltigani A; A L Mubarak M; Sabaa AA; Edesa W; A L-Tweigeri T; Al-Badawi IA
Med Oncol; 2012 Dec; 29(4):2944-8. PubMed ID: 22407668
[TBL] [Abstract][Full Text] [Related]
23. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
[TBL] [Abstract][Full Text] [Related]
24. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
26. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
28. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
30. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series.
Gallotta V; Ghezzi F; Vizza E; Fagotti A; Ceccaroni M; Fanfani F; Chiantera V; Ercoli A; Rossitto C; Conte C; Uccella S; Corrado G; Scambia G; Ferrandina G
J Minim Invasive Gynecol; 2016; 23(4):590-6. PubMed ID: 26872630
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Dysgerminoma: A Tertiary Center Experience.
Kilic C; Cakir C; Yuksel D; Kilic F; Kayikcioglu F; Koc S; Korkmaz V; Kimyon Comert G; Turkmen O; Boran N; Turan T
J Adolesc Young Adult Oncol; 2021 Jun; 10(3):303-308. PubMed ID: 32762565
[No Abstract] [Full Text] [Related]
33. CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer.
Memarzadeh S; Lee SB; Berek JS; Farias-Eisner R
Int J Gynecol Cancer; 2003; 13(2):120-4. PubMed ID: 12657110
[TBL] [Abstract][Full Text] [Related]
34. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.
Kasenda B; Harter P; Hirsch T; Ast A; Buhrmann C; Glaser F; Du Bois A
Acta Obstet Gynecol Scand; 2009; 88(11):1288-90. PubMed ID: 19900144
[TBL] [Abstract][Full Text] [Related]
35. Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Shibata K; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2019 Jun; 29(5):910-915. PubMed ID: 30839284
[TBL] [Abstract][Full Text] [Related]
36. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
Bian C; Yao K; Li L; Yi T; Zhao X
Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
[TBL] [Abstract][Full Text] [Related]
37. [Pure dysgerminoma of the ovary. 12 case reports].
Kdous M; Hachicha R; Gamoudi A; Boussen H; Benna F; Rahal K
Tunis Med; 2003 Dec; 81(12):937-43. PubMed ID: 14986529
[TBL] [Abstract][Full Text] [Related]
38. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
[TBL] [Abstract][Full Text] [Related]
39. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
[TBL] [Abstract][Full Text] [Related]
40. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]